Advanced search
Publication Cover
Journal of Chemotherapy Volume 26, 2014 - Issue 6
Submit an article Journal homepage
171
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis

Kazuki TakakuraDivision of Gastroenterology and HepatologyDivision of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, JapanCorrespondence[email protected]
,
Shigeo KoidoDivision of Gastroenterology and HepatologyDivision of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan
,
Akitaka TakaharaDivision of Gastroenterology and HepatologyDivision of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan
,
Shunichi OdaharaDivision of Gastroenterology and HepatologyDivision of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan
,
Jimi MitobeDivision of Gastroenterology and HepatologyDivision of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan
,
Hiroshi MatsudairaDivision of Gastroenterology and HepatologyDivision of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan
,
Shintaro TsukinagaDivision of Gastroenterology and HepatologyDivision of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan
,
Toyokazu YukawaDivision of Gastroenterology and HepatologyDivision of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan
,
Kei MatsumotoDivision of Nephrology and HypertensionDepartment of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan
,
Keisuke NagatsumaDivision of Gastroenterology and HepatologyDivision of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan
,
Kan UchiyamaDivision of Gastroenterology and HepatologyDivision of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan
,
Mikio KajiharaDivision of Gastroenterology and HepatologyDivision of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan
,
Toshifumi OhkusaDivision of Gastroenterology and HepatologyDivision of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan
&
Hisao TajiriDivision of Gastroenterology and HepatologyDepartment of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan;Department of EndoscopyThe Jikei University School of Medicine, Tokyo, Japan
 show all
Pages 369-372 | Published online: 06 Dec 2013

References

  • Gudjonsson B, Livestone EM, Spiro HM. Cancer of the pancreas: diagnostic accuracy and survival statistics. Cancer. 1978;42(5):2494–506.
  • Carmichael J. Clinical response benefit in patients with advanced pancreatic cancer. Role of gemcitabine. Digestion. 1997;58(6):503–7.
  • Cubiella J, Castells A, Fondevila C, Sans M, Sabater L, Navarro S, et al. Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials. Am J Gastroenterol. 1999;94(5):1271–8.
  • Kune GA, Eastman MC. Cancer of the pancreas. Factors affecting survival. Med J Aust. 1981;1(7): 361–3.
  • Venook AP, Egorin MJ, Rosner GL, Hollis D, Mani S, Hawkins M, et al. Phase Ι and pharmacokinetics trial of gemcitabine in patients with hepatic or renal dysfunction: cancer and leukiemia group B 9565. J Clin Oncol. 2000;18: 2780–7.
  • Kiani A, Köhne CH, Franz T, Passauer J, Haufe T, Gross P, et al. Pharmacokinetics of gemcitabine in a patient with end-stage renal disease: effective clearance of its main metabolite by standard hemodialysis treatment. Cancer Chemother Pharmacol. 2003;51:266–70.
  • Pini TM, Rothenberg ML, Nicol S, Kaplan M, Egorin MJ. Pharmacokinetics of gemcitabine in a patient with renal failure on hemodialysis. Proc Am Soc Clin Oncol. 2003;22:abstr 630.
  • Delaloge S, Llombart A, Di Palma M, Tourani JM, Turpin F, Ni L, et al. Gemcitabine in patients with solid tumors and renal impairment: a pharmacokinetic phase Ι study. Am J Clin Oncol. 2004;27:289–93.
  • Sobin LH, Witterkind Ch, editors. TNM classification of malignant tumours (UICC). 7th ed. New York: Wiley-Liss; 2010.
  • Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
  • Common Terminology Criteria for Adverse Events v4.0-JCOG. Available from: http://www.jcog.jp/
  • Guchelaar HJ, Richel DJ, van Knapen A. Clinical, toxicological and pharmacological aspects of gemcitabine. Cancer Treat Rev. 1996;22:15–31.
  • Storniolo AM, Allerheiligen SR, Pearce HL. Preclinical, pharmacologic, and phase I studies of gemcitabine. Semin Oncol. 1997;24:S7-2–7.
  • Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet. 1999;354:93–9.
  • Eneman JD, Philips GK. Cancer management in patients with end-stage renal disease. Oncology (Williston Park). 2005;19:1199–212.
  • The interview form of Gemzar® injection. Available from: http://www.lillyanswers.jp/data/static/if/if_gem_200609.pdf
  • Matsuda M. Gemcitabine for patients with chronic renal failure on hemodialysis. ASCO Annual Meeting Proceedings Part Ι. J Clin Oncol. 2007;25:abstr 15189.
  • Masumori N, Kunishima Y, Hirobe M, Takeuchi M, Takayanagi A, Tsukamoto T, et al. Measurement of plasma concentration of gemcitabine and its metabolite dFdU in hemodialysis patients with advanced urothelial cancer. Jpn J Clin Oncol. 2008;38(3):182–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.